These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21450091)

  • 21. Clinical and histological predictors of contralateral breast cancer.
    Kollias J; Ellis IO; Elston CW; Blamey RW
    Eur J Surg Oncol; 1999 Dec; 25(6):584-9. PubMed ID: 10556004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mortality after contralateral breast cancer in Denmark.
    Langballe R; Frederiksen K; Jensen MB; Andersson M; Cronin-Fenton D; Ejlertsen B; Mellemkjær L
    Breast Cancer Res Treat; 2018 Sep; 171(2):489-499. PubMed ID: 29948403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concordance in histological and biological parameters between first and second primary breast cancers.
    Huo D; Melkonian S; Rathouz PJ; Khramtsov A; Olopade OI
    Cancer; 2011 Mar; 117(5):907-15. PubMed ID: 20945326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contralateral breast cancer: annual incidence and risk parameters.
    Broët P; de la Rochefordière A; Scholl SM; Fourquet A; Mosseri V; Durand JC; Pouillart P; Asselain B
    J Clin Oncol; 1995 Jul; 13(7):1578-83. PubMed ID: 7602346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammographic breast density is associated with the development of contralateral breast cancer.
    Raghavendra A; Sinha AK; Le-Petross HT; Garg N; Hsu L; Patangan M; Bevers TB; Shen Y; Banu A; Tripathy D; Bedrosian I; Barcenas CH
    Cancer; 2017 Jun; 123(11):1935-1940. PubMed ID: 28135395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study.
    Knight JA; Blackmore KM; Fan J; Malone KE; John EM; Lynch CF; Vachon CM; Bernstein L; Brooks JD; Reiner AS; Liang X; Woods M; ; Bernstein JL
    Breast Cancer Res; 2018 Mar; 20(1):23. PubMed ID: 29566728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of synchronous and metachronous bilateral breast cancer.
    Kollias J; Ellis IO; Elston CW; Blamey RW
    World J Surg; 2001 Sep; 25(9):1117-24. PubMed ID: 11571945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of isolated local breast cancer recurrence and contralateral breast cancer: A systematic review.
    Spronk I; Schellevis FG; Burgers JS; de Bock GH; Korevaar JC
    Breast; 2018 Jun; 39():70-79. PubMed ID: 29621695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands.
    Schaapveld M; Visser O; Louwman WJ; Willemse PH; de Vries EG; van der Graaf WT; Otter R; Coebergh JW; van Leeuwen FE
    Breast Cancer Res Treat; 2008 Jul; 110(1):189-97. PubMed ID: 17687645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival Outcomes and Pathologic Features Among Breast Cancer Patients Who Have Developed a Contralateral Breast Cancer.
    Liederbach E; Wang CH; Lutfi W; Kantor O; Pesce C; Winchester DJ; Yao K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S412-21. PubMed ID: 26334294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contralateral breast cancer: a clinico-pathological study of second primaries in opposite breasts after treatment of breast malignancy.
    Shankar A; Roy S; Malik A; Kamal VK; Bhandari R; Kishor K; Mahajan M; Sachdev J; Jeyaraj P; Rath G
    Asian Pac J Cancer Prev; 2015; 16(3):1207-11. PubMed ID: 25735357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study.
    Langballe R; Mellemkjær L; Malone KE; Lynch CF; John EM; Knight JA; Bernstein L; Brooks J; Andersson M; Reiner AS; Liang X; Woods M; Concannon PJ; ; Bernstein JL
    Breast Cancer Res; 2016 Jul; 18(1):65. PubMed ID: 27400983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiologic and molecular risk factors for contralateral breast cancer among young women.
    Li CI; Malone KE; Porter PL; Daling JR
    Br J Cancer; 2003 Aug; 89(3):513-8. PubMed ID: 12888823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors of developing contralateral breast cancer after first primary breast cancer treatment.
    Avatefi M; HadavandSiri F; Nazari SSH; Akbari ME
    Cancer Rep (Hoboken); 2024 Jan; 7(1):e1927. PubMed ID: 37919558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synchronous and metachronous bilateral breast cancer: A long-term experience.
    Ozturk A; Alco G; Sarsenov D; Ilgun S; Ordu C; Koksal U; Nur Pilanci K; Erdogan Z; Izci F; Elbuken F; Agacayak F; Aktepe F; Ozmen V
    J BUON; 2018; 23(6):1591-1600. PubMed ID: 30610782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased risk of contralateral breast cancers among overweight and obese women: a time-dependent association.
    Majed B; Dozol A; Ribassin-Majed L; Senouci K; Asselain B
    Breast Cancer Res Treat; 2011 Apr; 126(3):729-38. PubMed ID: 20872242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second primary in the contralateral breast after treatment of breast cancer.
    Yadav BS; Sharma SC; Patel FD; Ghoshal S; Kapoor RK
    Radiother Oncol; 2008 Feb; 86(2):171-6. PubMed ID: 17961777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reproductive history and risk of second primary breast cancer: the WECARE study.
    Largent JA; Capanu M; Bernstein L; Langholz B; Mellemkaer L; Malone KE; Begg CB; Haile RW; Lynch CF; Anton-Culver H; Wolitzer A; Bernstein JL
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):906-11. PubMed ID: 17507614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors for metachronous contralateral breast cancer: a comparison of the linear Cox regression model and its artificial neural network extension.
    Mariani L; Coradini D; Biganzoli E; Boracchi P; Marubini E; Pilotti S; Salvadori B; Silvestrini R; Veronesi U; Zucali R; Rilke F
    Breast Cancer Res Treat; 1997 Jun; 44(2):167-78. PubMed ID: 9232275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer.
    van Gestel YR; Thomassen I; Lemmens VE; Pruijt JF; van Herk-Sukel MP; Rutten HJ; Creemers GJ; de Hingh IH
    Eur J Surg Oncol; 2014 Aug; 40(8):963-9. PubMed ID: 24183168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.